ReP USP - Resultado da busca

Artigo de periodico
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases (2019)
Betts, Matthew J; Kirilina, Evgeniya; Otaduy, Maria C. G; Ivanov, Dimo; Acosta-cabronero, Julio; Callaghan, Martina F; Lambert, Christian; Cardenas-blanco, Arturo; Pine, Kerrin; Grinberg, Lea Tenenholz
Fonte: Brain. Unidade: FM
Assuntos: BIOMARCADORES, DOENÇAS NEURODEGENERATIVAS, NEURÔNIOS, IMAGEM POR RESSONÂNCIA MAGNÉTICA, NORADRENALINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BETTS, Matthew J et al. Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain, v. 142, p. 2558-2571, 2019Tradução . . Disponível em: https://doi.org/10.1093/brain/awz193. Acesso em: 03 jun. 2024.
APA
Betts, M. J., Kirilina, E., Otaduy, M. C. G., Ivanov, D., Acosta-cabronero, J., Callaghan, M. F., et al. (2019). Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain, 142, 2558-2571. doi:10.1093/brain/awz193
NLM
Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-cabronero J, Callaghan MF, Lambert C, Cardenas-blanco A, Pine K, Grinberg LT. Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases [Internet]. Brain. 2019 ; 142 2558-2571.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1093/brain/awz193
Vancouver
Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-cabronero J, Callaghan MF, Lambert C, Cardenas-blanco A, Pine K, Grinberg LT. Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases [Internet]. Brain. 2019 ; 142 2558-2571.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1093/brain/awz193
Artigo de periodico
Non-motor outcomes depend on location of neurostimulation in Parkinson's disease (2019)
Petry-schmelzer, Jan Niklas; Krause, Max; Dembek, Till A; Horn, Andreas; Evans, Julian; Ashkan, Keyoumars; Rizos, Alexandra; Silverdale, Monty; Schumacher, Wibke; Fonoff, Erich Talamoni
Fonte: Brain. Unidade: FM
Assuntos: DOENÇA DE PARKINSON, ESTIMULAÇÃO CEREBRAL, NÚCLEOS TALÂMICOS, ESTUDOS PROSPECTIVOS, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETRY-SCHMELZER, Jan Niklas et al. Non-motor outcomes depend on location of neurostimulation in Parkinson's disease. Brain, v. 142, p. 3592-3604, 2019Tradução . . Disponível em: https://doi.org/10.1093/brain/awz285. Acesso em: 03 jun. 2024.
APA
Petry-schmelzer, J. N., Krause, M., Dembek, T. A., Horn, A., Evans, J., Ashkan, K., et al. (2019). Non-motor outcomes depend on location of neurostimulation in Parkinson's disease. Brain, 142, 3592-3604. doi:10.1093/brain/awz285
NLM
Petry-schmelzer JN, Krause M, Dembek TA, Horn A, Evans J, Ashkan K, Rizos A, Silverdale M, Schumacher W, Fonoff ET. Non-motor outcomes depend on location of neurostimulation in Parkinson's disease [Internet]. Brain. 2019 ; 142 3592-3604.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1093/brain/awz285
Vancouver
Petry-schmelzer JN, Krause M, Dembek TA, Horn A, Evans J, Ashkan K, Rizos A, Silverdale M, Schumacher W, Fonoff ET. Non-motor outcomes depend on location of neurostimulation in Parkinson's disease [Internet]. Brain. 2019 ; 142 3592-3604.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1093/brain/awz285
Artigo de periodico
BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells (2018)
Lessel, Davor; Jorge, Alexander A. L.
Fonte: Brain. Unidade: FM
Assuntos: DESENVOLVIMENTO INTELECTUAL, INFLAMAÇÃO, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LESSEL, Davor e JORGE, Alexander A. L. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells. Brain, v. 141, p. 2299-2311, 2018Tradução . . Disponível em: https://doi.org/10.1093/brain/awy173. Acesso em: 03 jun. 2024.
APA
Lessel, D., & Jorge, A. A. L. (2018). BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells. Brain, 141, 2299-2311. doi:10.1093/brain/awy173
NLM
Lessel D, Jorge AAL. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells [Internet]. Brain. 2018 ; 141 2299-2311.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1093/brain/awy173
Vancouver
Lessel D, Jorge AAL. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells [Internet]. Brain. 2018 ; 141 2299-2311.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1093/brain/awy173
Artigo de periodico
A novel complex neurological phenotype due to a homozygous mutation in FDX2 (2018)
Gurgel-giannetti, Juliana; Kok, Fernando
Fonte: Brain. Unidade: FM
Assuntos: FENÓTIPOS, MIOPATIAS CONGÊNITAS ESTRUTURAIS, ATROFIA MUSCULAR, SEQUENCIAMENTO GENÉTICO, IMAGEM POR RESSONÂNCIA MAGNÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GURGEL-GIANNETTI, Juliana e KOK, Fernando. A novel complex neurological phenotype due to a homozygous mutation in FDX2. Brain, v. 141, p. 2289-2298, 2018Tradução . . Disponível em: https://doi.org/10.1093/brain/awy172. Acesso em: 03 jun. 2024.
APA
Gurgel-giannetti, J., & Kok, F. (2018). A novel complex neurological phenotype due to a homozygous mutation in FDX2. Brain, 141, 2289-2298. doi:10.1093/brain/awy172
NLM
Gurgel-giannetti J, Kok F. A novel complex neurological phenotype due to a homozygous mutation in FDX2 [Internet]. Brain. 2018 ; 141 2289-2298.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1093/brain/awy172
Vancouver
Gurgel-giannetti J, Kok F. A novel complex neurological phenotype due to a homozygous mutation in FDX2 [Internet]. Brain. 2018 ; 141 2289-2298.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1093/brain/awy172

Unidades USP

ReP

Filtros

Autores

Assuntos

Agência de fomento